ID   GLR_RAT                 Reviewed;         485 AA.
AC   P30082;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 2.
DT   24-JUL-2024, entry version 162.
DE   RecName: Full=Glucagon receptor;
DE            Short=GL-R;
DE   Flags: Precursor;
GN   Name=Gcgr;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=8384375; DOI=10.1126/science.8384375;
RA   Jelinek L.J., Lok S., Grant F.J., Rosenberg G.B., Smith R.A., Bensch P.A.,
RA   Sheppard P.O., O'Hara P.J., Foster D.C., Kuijper J.L., Biggs S.H.,
RA   Walker K.M., Chen L.H., McKernan P.A., Kindsvogel W.;
RT   "Expression cloning and signaling properties of the rat glucagon
RT   receptor.";
RL   Science 259:1614-1616(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8384842; DOI=10.1006/bbrc.1993.1243;
RA   Svoboda M., Ciccarelli E., Tastenoy M., Cauvin A., Stievenart M.,
RA   Christophe J.;
RT   "Small introns in a hepatic cDNA encoding a new glucagon-like peptide 1-
RT   type receptor.";
RL   Biochem. Biophys. Res. Commun. 191:479-486(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Wistar; TISSUE=Liver;
RX   PubMed=8082779; DOI=10.1016/0014-5793(94)00875-2;
RA   Maget B., Tastenoy M., Svoboda M.;
RT   "Sequencing of eleven introns in genomic DNA encoding rat glucagon receptor
RT   and multiple alternative splicing of its mRNA.";
RL   FEBS Lett. 351:271-275(1994).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-476, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: G-protein coupled receptor for glucagon that plays a central
CC       role in the regulation of blood glucose levels and glucose homeostasis.
CC       Regulates the rate of hepatic glucose production by promoting glycogen
CC       hydrolysis and gluconeogenesis. Plays an important role in mediating
CC       the responses to fasting. Ligand binding causes a conformation change
CC       that triggers signaling via guanine nucleotide-binding proteins (G
CC       proteins) and modulates the activity of down-stream effectors, such as
CC       adenylate cyclase. Promotes activation of adenylate cyclase. Besides,
CC       plays a role in signaling via a phosphatidylinositol-calcium second
CC       messenger system. {ECO:0000269|PubMed:8384375}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:8384375};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:8384375}. Note=Is
CC       rapidly internalized after ligand-binding.
CC       {ECO:0000250|UniProtKB:P47871}.
CC   -!- PTM: Ligand-binding promotes phosphorylation of serine residues in the
CC       C-terminal cytoplasmic domain. Phosphorylation is important for
CC       receptor endocytosis after ligand-binding (By similarity).
CC       {ECO:0000250|UniProtKB:P47871}.
CC   -!- MISCELLANEOUS: Selective recognition of glucagon over glucagon-like
CC       peptide is determined by residues located at the N-terminal end of the
CC       glucagon peptide. {ECO:0000250|UniProtKB:A0A2Z2U4G9}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 2 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L04796; AAA16439.1; -; mRNA.
DR   EMBL; X68692; CAA48651.1; -; mRNA.
DR   EMBL; M96674; AAA02992.1; -; mRNA.
DR   EMBL; U63021; AAB16800.1; -; Genomic_DNA.
DR   PIR; JQ1957; JQ1957.
DR   RefSeq; NP_742088.1; NM_172091.2.
DR   RefSeq; NP_742089.1; NM_172092.2.
DR   RefSeq; XP_006247938.1; XM_006247876.3.
DR   AlphaFoldDB; P30082; -.
DR   SMR; P30082; -.
DR   STRING; 10116.ENSRNOP00000051845; -.
DR   BindingDB; P30082; -.
DR   ChEMBL; CHEMBL4720; -.
DR   DrugCentral; P30082; -.
DR   GuidetoPHARMACOLOGY; 251; -.
DR   GlyCosmos; P30082; 4 sites, No reported glycans.
DR   GlyGen; P30082; 4 sites.
DR   iPTMnet; P30082; -.
DR   PhosphoSitePlus; P30082; -.
DR   PaxDb; 10116-ENSRNOP00000051845; -.
DR   Ensembl; ENSRNOT00000054962.3; ENSRNOP00000051845.1; ENSRNOG00000036692.5.
DR   Ensembl; ENSRNOT00065005752; ENSRNOP00065004149; ENSRNOG00065003924.
DR   GeneID; 24953; -.
DR   KEGG; rno:24953; -.
DR   AGR; RGD:2669; -.
DR   CTD; 2642; -.
DR   RGD; 2669; Gcgr.
DR   eggNOG; KOG4564; Eukaryota.
DR   GeneTree; ENSGT00940000157969; -.
DR   HOGENOM; CLU_002753_4_0_1; -.
DR   InParanoid; P30082; -.
DR   OMA; HWHRWRL; -.
DR   OrthoDB; 4209404at2759; -.
DR   PhylomeDB; P30082; -.
DR   TreeFam; TF315710; -.
DR   Reactome; R-RNO-163359; Glucagon signaling in metabolic regulation.
DR   Reactome; R-RNO-416476; G alpha (q) signalling events.
DR   Reactome; R-RNO-420092; Glucagon-type ligand receptors.
DR   PRO; PR:P30082; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000036692; Expressed in liver and 18 other cell types or tissues.
DR   ExpressionAtlas; P30082; baseline and differential.
DR   GO; GO:0005768; C:endosome; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0004967; F:glucagon receptor activity; IDA:RGD.
DR   GO; GO:0017046; F:peptide hormone binding; IDA:RGD.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IDA:RGD.
DR   GO; GO:0007188; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; IMP:RGD.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0071377; P:cellular response to glucagon stimulus; ISO:RGD.
DR   GO; GO:0009267; P:cellular response to starvation; ISO:RGD.
DR   GO; GO:0006887; P:exocytosis; IDA:RGD.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IDA:RGD.
DR   GO; GO:0042593; P:glucose homeostasis; ISS:UniProtKB.
DR   GO; GO:0009755; P:hormone-mediated signaling pathway; IDA:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0070873; P:regulation of glycogen metabolic process; ISS:UniProtKB.
DR   GO; GO:0042594; P:response to starvation; ISS:UniProtKB.
DR   CDD; cd15267; 7tmB1_GCGR; 1.
DR   Gene3D; 4.10.1240.10; GPCR, family 2, extracellular hormone receptor domain; 1.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR050332; GPCR_2.
DR   InterPro; IPR017981; GPCR_2-like_7TM.
DR   InterPro; IPR036445; GPCR_2_extracell_dom_sf.
DR   InterPro; IPR001879; GPCR_2_extracellular_dom.
DR   InterPro; IPR003290; GPCR_2_GLP1/glucagon_rcpt.
DR   InterPro; IPR003291; GPCR_2_glucagon_rcpt.
DR   InterPro; IPR000832; GPCR_2_secretin-like.
DR   InterPro; IPR017983; GPCR_2_secretin-like_CS.
DR   PANTHER; PTHR45620:SF29; GLUCAGON RECEPTOR; 1.
DR   PANTHER; PTHR45620; PDF RECEPTOR-LIKE PROTEIN-RELATED; 1.
DR   Pfam; PF00002; 7tm_2; 1.
DR   Pfam; PF02793; HRM; 1.
DR   PRINTS; PR01353; GLUCAGNFAMLY.
DR   PRINTS; PR01354; GLUCAGONR.
DR   PRINTS; PR00249; GPCRSECRETIN.
DR   SMART; SM00008; HormR; 1.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   SUPFAM; SSF111418; Hormone receptor domain; 1.
DR   PROSITE; PS00649; G_PROTEIN_RECEP_F2_1; 1.
DR   PROSITE; PS00650; G_PROTEIN_RECEP_F2_2; 1.
DR   PROSITE; PS50227; G_PROTEIN_RECEP_F2_3; 1.
DR   PROSITE; PS50261; G_PROTEIN_RECEP_F2_4; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Disulfide bond; G-protein coupled receptor; Glycoprotein;
KW   Membrane; Phosphoprotein; Receptor; Reference proteome; Signal; Transducer;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000255"
FT   CHAIN           27..485
FT                   /note="Glucagon receptor"
FT                   /id="PRO_0000012834"
FT   TOPO_DOM        27..137
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P47871"
FT   TRANSMEM        138..162
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250|UniProtKB:P47871"
FT   TOPO_DOM        163..174
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P47871"
FT   TRANSMEM        175..199
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250|UniProtKB:P47871"
FT   TOPO_DOM        200..226
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P47871"
FT   TRANSMEM        227..250
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250|UniProtKB:P47871"
FT   TOPO_DOM        251..264
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P47871"
FT   TRANSMEM        265..286
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250|UniProtKB:P47871"
FT   TOPO_DOM        287..304
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P47871"
FT   TRANSMEM        305..327
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250|UniProtKB:P47871"
FT   TOPO_DOM        328..351
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P47871"
FT   TRANSMEM        352..370
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250|UniProtKB:P47871"
FT   TOPO_DOM        371..382
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:P47871"
FT   TRANSMEM        383..403
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250|UniProtKB:P47871"
FT   TOPO_DOM        404..485
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:P47871"
FT   REGION          351..354
FT                   /note="Important for allosteric inhibitor binding"
FT                   /evidence="ECO:0000250|UniProtKB:P47871"
FT   REGION          455..485
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         460
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P47871"
FT   MOD_RES         476
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CARBOHYD        47
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        60
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        75
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        79
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        44..68
FT                   /evidence="ECO:0000250|UniProtKB:P47871"
FT   DISULFID        59..101
FT                   /evidence="ECO:0000250|UniProtKB:P47871"
FT   DISULFID        82..122
FT                   /evidence="ECO:0000250|UniProtKB:P47871"
FT   DISULFID        225..295
FT                   /evidence="ECO:0000250|UniProtKB:P47871"
FT   CONFLICT        216
FT                   /note="W -> C (in Ref. 2)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        324
FT                   /note="V -> A (in Ref. 2)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   485 AA;  55038 MW;  91AC67D7A4F5090E CRC64;
     MLLTQLHCPY LLLLLVVLSC LPKAPSAQVM DFLFEKWKLY SDQCHHNLSL LPPPTELVCN
     RTFDKYSCWP DTPPNTTANI SCPWYLPWYH KVQHRLVFKR CGPDGQWVRG PRGQSWRDAS
     QCQMDDDEIE VQKGVAKMYS SYQVMYTVGY SLSLGALLLA LVILLGLRKL HCTRNYIHGN
     LFASFVLKAG SVLVIDWLLK TRYSQKIGDD LSVSVWLSDG AVAGCRVATV IMQYGIIANY
     CWLLVEGVYL YSLLSITTFS EKSFFSLYLC IGWGSPLLFV IPWVVVKCLF ENVQCWTSND
     NMGFWWILRI PVLLAILINF FIFVRIIHLL VAKLRAHQMH YADYKFRLAR STLTLIPLLG
     VHEVVFAFVT DEHAQGTLRS TKLFFDLFFS SFQGLLVAVL YCFLNKEVQA ELLRRWRRWQ
     EGKALQEERM ASSHGSHMAP AGTCHGDPCE KLQLMSAGSS SGTGCEPSAK TSLASSLPRL
     ADSPT
//
